Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis

BackgroundAdvanced biliary tract cancer (BTC) is associated with a poor prognosis and limited options for second-line treatment. The TOPAZ-1 and KEYNOTE-966 trials have demonstrated the benefits of combining immune checkpoint inhibitors (ICIs) with chemotherapy in treating BTC. However, the efficacy...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Peipei Shang, Heming Xu, Tianmei Zeng, Cheng Lou, Wei Wei, Guang Yang, Zhuo Cheng, Xiaowen Cui, Weipeng Hong, Weidong Shen, Zhicong Lian, Zhengang Yuan
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2024-11-01
Seria:	Frontiers in Oncology
Hasła przedmiotowe:	BTC second-line therapy immunotherapy combination (combined) therapy retrospective studies
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1482909/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!